JP Morgan Upgrades Forest Laboratories To Overweight, PT Raised To $41

June 3, 2011 6:56 AM | 11 seconds read | Make a Comment

JP Morgan has upgraded Forest Laboratories

FRX

from Neutral to Overweight and has raised the price target from $38 to $41 as a favorable risk/reward profile is being witnessed for the stock.

Posted In: Upgrades Price Target Analyst Ratings forest laboratories Health Care JP Morgan Pharmaceuticals

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.